Shaji Kumar, MD

Vice President

Shaji Kumar, MD is a consultant in the Division of Hematology at Mayo Clinic, and Professor of Medicine in the College of Medicine, Mayo Clinic, Rochester, MN. He is currently the Medical Director for the Cancer Center Clinical Trials Office. He also serves as the co-chair of the NCI Myeloma Steering Committee.

Dr. Kumar’s research efforts are directed toward studying novel treatment approaches in myeloma through well-designed clinical trials. Currently he is principal investigator on multiple phase I, II, and III trials for plasma cell malignancies, His laboratory efforts are focused on development of new agents for plasma cell malignancies, with a particular focus on the tumor microenvironment and its interaction with the tumor cells and understanding the risk of progression of monoclonal gammopathies including MGUS and smoldering myeloma.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

See All of the Member Benefits

Become a Member Today

Stay updated on our Events

Become a Member

Name*
First Last
Title (MD, PhD, etc)
Birth Date
MM slash DD slash YYYY
Email Address*
Enter Email Confirm Email
Admin Assistant Email Address
Password*
Enter Password Confirm Password
Medical Center
Country*
Consent
Sign-Up for Our Newsletter?

Shaji Kumar, MD

Why Become a Member

Stay updated on our Events

Already a Member

Reset Password

Become a Member